AAAAAA
Results:
1-8
|
Results: 8
Authors:
Venook, AP
Warren, RS
Citation: Ap. Venook et Rs. Warren, Introduction: Hepatocellular carcinoma, SEMIN ONCOL, 28(5), 2001, pp. 439-440
Authors:
Bergsland, EK
Venook, AP
Citation: Ek. Bergsland et Ap. Venook, Hepatocellular carcinoma, CURR OPIN O, 12(4), 2000, pp. 357-361
Authors:
Venook, AP
Citation: Ap. Venook, Regional strategies for managing hepatocellular carcinoma, ONCOLOGY-NY, 14(3), 2000, pp. 347
Authors:
Venook, AP
Egorin, MJ
Rosner, GL
Hollis, D
Mani, S
Hawkins, M
Byrd, J
Hohl, R
Budman, D
Meropol, NJ
Ratain, MJ
Citation: Ap. Venook et al., Phase I and pharmacokinetic trial of gemcitabine in patients with hepatic or renal dysfunction: Cancer and leukemia group B 9565, J CL ONCOL, 18(14), 2000, pp. 2780-2787
Authors:
Venook, AP
Althaus, B
Warren, RS
Citation: Ap. Venook et al., Hepatic arterial infusion of chemotherapy for metastatic colorectal cancer, N ENG J MED, 342(20), 2000, pp. 1524-1524
Authors:
Bloom, AI
Gordon, RL
Ahl, KH
Kerlan, RK
LaBerge, JM
Wilson, MW
Venook, AP
Warren, R
Citation: Ai. Bloom et al., Transcatheter embolization for the treatment of misperfusion after hepaticartery chemoinfusion pump implantation, ANN SURG O, 6(4), 1999, pp. 350-358
Authors:
Rubin, J
Ajani, J
Schirmer, W
Venook, AP
Bukowski, R
Pommier, R
Saltz, L
Dandona, P
Anthony, L
Citation: J. Rubin et al., Octreotide acetate long-acting formulation versus open-label subcutaneous octreotide acetate in malignant carcinoid syndrome, J CL ONCOL, 17(2), 1999, pp. 600-606
Authors:
Venook, AP
Citation: Ap. Venook, p53 gene therapy for liver tumors, MALIGNANT LIVER TUMORS, 1999, pp. 229-233
Risultati:
1-8
|